A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Recruiting now
Conditions studied: Neovascular (Wet) Age-related Macular Degeneration
In brief
This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) will undergo safety and efficacy assessments up to 5 years post study drug injection.
Key facts
- Study ID
- NCT06346600
- Run by
- Skyline Therapeutics
- People needed
- 83
- Starts
- 2024-04-02
- Expected to finish
- 2031-03-01
- Last updated by the study team
- 2024-04-04
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects who only meet all of the following criteria are eligible for this study:
- nAMD subjects who have been enrolled in the SKG0106-related study and received SKG0106 injection;
- Subjects who voluntarily sign an informed consent form (ICF) and comply with the protocol to complete the study
You may not qualify if…
- Subjects who are judged by the investigator unsuitable for this study
Where it is running
- EYE & ENT Hospital of Fudan University — Shanghai, China (enrolling)
- Peking Union Medical College Hospital — Beijing, China (enrolling)
- Wagner Macula & Retina Center — Norfolk, Virginia, United States
- The Second Hospital Of Anhui Medical University — Hefei, Anhui, China
- Zhejiang Provincial People's Hospital — Hangzhou, Zhejiang, China
- Eye Hospital, WMU (Zhejiang Eye Hospital) — Wenzhou, Zhejiang, China
- Beijing Hospital — Beijing, China
- Ophthalmic Consultants of Boston — Boston, Massachusetts, United States
- Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine — Shanghai, China
- Retina Consultants of Texas — Katy, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.